Skip to main content
. 2019 Dec 16;2(6):441–449. doi: 10.1089/crispr.2019.0034

Table 2.

Comparison of SCD stakeholders with genetics professionals

  Patients/parents, N = 75 Genetics professionals, N = 472 χ2, p-value
Parents and guardians have a right to edit genes of their children before they are born
Agree strongly/agree 33 (44.0%) 207 (43.9%) 0.036, p = 0.98
Neutral 19 (25.3%) 124 (26.3%)
Disagree strongly/disagree 23 (30.7%) 141 (29.9%)
Missing 0 (0%) 0 (0%)
Germline human gene editing is acceptable if alternative treatments are more expensive
Agree strongly/agree 29 (38.7%) 180 (38.1%) 2.48, p = 0.48
Neutral 23 (30.7%) 115 (24.4%)
Disagree strongly/disagree 22 (29.3%) 174 (36.9%)
Missing 1 (1.3%) 3 (0.6%)
Germline human gene editing is acceptable if there are no alternative treatments available
Agree strongly/agree 38 (50.7%) 286 (60.6%) 3.20, p = 0.36
Neutral 20 (26.7%) 99 (21.0%)
Disagree strongly/disagree 15 (20.0%) 81 (17.2%)
Missing 2 (2.7%) 6 (1.3%)
Germline human gene editing goes against my cultural beliefs
Agree strongly/agree 19 (25.3%) 65 (13.8%) 12.44, p = 0.006
Neutral 20 (26.7%) 82 (17.4%)
Disagree strongly/disagree 36 (48.0%) 320 (67.8%)
Missing 0 (0%) 5 (1.1%)
Germline human gene editing goes against my religious beliefs
Agree strongly/agree 16 (21.3%) 52 (11.0%) 12.83, p = 0.005
Neutral 18 (24.0%) 69 (14.6%)
Disagree strongly/disagree 40 (53.3%) 345 (73.1%)
Missing 1 (1.3%) 4 (0.9%)
Germline human gene editing is morally acceptable
Agree strongly/agree 18 (24.0%) 225 (47.7%) 16.29, p = 0.001
Neutral 31 (41.3%) 147 (31.1%)
Disagree strongly/disagree 26 (34.7%) 95 (20.1%)
Missing 0 (0%) 5 (1.1%)

Bold values indicate statistical significance.